| |
 |
|
Class Information
Number: 424/261.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Vibrio (e.g., vibrio cholera, etc.)
Description: Subject matter wherein the bacterium is of the genus Vibrio.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7384639 |
Methods of treating or preventing an infectious disease using an immunogenic conjugate of a gram-negative bacterial autoinducer molecule |
Jun. 10, 2008 |
| 7361355 |
Mutant forms of cholera holotoxin as an adjuvant |
Apr. 22, 2008 |
| 7332174 |
Mutant forms of cholera holotoxin as an adjuvant |
Feb. 19, 2008 |
| 7285281 |
Mutant forms of cholera holotoxin as an adjuvant |
Oct. 23, 2007 |
| 7261899 |
Method of producing thy A-strains of Vibrio cholerae, such strains and their use |
Aug. 28, 2007 |
| 7160549 |
Methods for making compositions including gram negative microbial polypeptides |
Jan. 9, 2007 |
| 7090853 |
Noscapine derivatives as adjuvant compositions and methods of use thereof |
Aug. 15, 2006 |
| 7090856 |
Anti-fouling exopolysaccharides isolated from cultures of Vibrio alginolyticus and Vibrio proteolyticus |
Aug. 15, 2006 |
| 7070781 |
Nontoxic mucosal adjuvant |
Jul. 4, 2006 |
| 7063852 |
Hybrid LT-A/CT-B holotoxin for use as an adjuvant |
Jun. 20, 2006 |
| 7056521 |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
Jun. 6, 2006 |
| 7037499 |
Adjuvant for transcutaneous immunization |
May. 2, 2006 |
| 6913757 |
Live, avirulent strain of V. anguillarum that protects fish against infection by virulent V. anguillarum and method of making the same |
Jul. 5, 2005 |
| 6811787 |
Over-expressing homologous antigen vaccine and a method of making the same |
Nov. 2, 2004 |
| 6733762 |
Method of using Zot to inhibit lymphocyte proliferation in an antigen-specific manner |
May. 11, 2004 |
| 6723323 |
Vibrio Cholerae vaccine candidates and method of their constructing |
Apr. 20, 2004 |
| 6613321 |
Live vaccines against gram-negative pathogens, expressing heterologous O-antigens |
Sep. 2, 2003 |
| 6548287 |
Non-pyrogenic bacterial strains and use of the same |
Apr. 15, 2003 |
| 6444210 |
Bacterial and synthetic polysaccharide immunomodulators that enhance general immunity |
Sep. 3, 2002 |
| 6440423 |
Mutant enterotoxin effective as a non-toxic oral adjuvant |
Aug. 27, 2002 |
| 6426075 |
Protease-activatable pseudomonas exotoxin A-like proproteins |
Jul. 30, 2002 |
| 6395964 |
Oral immunization with transgenic plants |
May. 28, 2002 |
| 6290962 |
Urease-based vaccine and treatment for helicobacter infection |
Sep. 18, 2001 |
| 6270777 |
Conserved metalloprotease epitopes |
Aug. 7, 2001 |
| 6255097 |
Two-phase system for the production and presentation of foreign antigens in hybrid live vaccines |
Jul. 3, 2001 |
| 6203799 |
Vibrio cholerae mutants which are soft-agar penetration defective and lack a functional CtxA subunit |
Mar. 20, 2001 |
| 6162433 |
Non antibiotic selectable markers for live vaccines |
Dec. 19, 2000 |
| 6149920 |
Over-expressing homologous antigen vaccine and a method of making the same |
Nov. 21, 2000 |
| 6149919 |
Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines |
Nov. 21, 2000 |
| 6106843 |
Process for the isolation of a nontoxinogenic vibrio cholerae strain and a process for preparing cholera vaccine from said vibrio cholerae strain |
Aug. 22, 2000 |
| 6060067 |
Process for the preparation of tetanus toxoid vaccine |
May. 9, 2000 |
| 6060068 |
Human IL-2 as a vaccine adjuvant |
May. 9, 2000 |
| 6054127 |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
Apr. 25, 2000 |
| 6036953 |
Heterologous antigens in live cell V. cholerae strains |
Mar. 14, 2000 |
| 6019973 |
Hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits |
Feb. 1, 2000 |
| 6019982 |
Mutant enterotoxin effective as a non-toxic oral adjuvant |
Feb. 1, 2000 |
| 5997881 |
Method of making non-pyrogenic lipopolysaccharide or A |
Dec. 7, 1999 |
| 5980907 |
Vaccines containing bacteria attenuated by mutation of the htrA gene |
Nov. 9, 1999 |
| 5951987 |
Polysaccharide vaccine to enhance immunity against brucellosis |
Sep. 14, 1999 |
| 5912323 |
Zonula occludens toxin receptors |
Jun. 15, 1999 |
| 5908825 |
Dosage composition for nasal delivery and method of use of the same |
Jun. 1, 1999 |
| 5882653 |
Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof |
Mar. 16, 1999 |
| 5874088 |
Deletion mutants of cholera vaccines expressing heterologous antigens |
Feb. 23, 1999 |
| 5864014 |
Zonula occludens toxin receptor |
Jan. 26, 1999 |
| 5804198 |
Vaccines against disease caused by pathogenic pilus-forming bacteria |
Sep. 8, 1998 |
| 5804199 |
Oil-based and water-based adjuvant mixture |
Sep. 8, 1998 |
| 5780040 |
Helicobacter pylori nickel binding protein |
Jul. 14, 1998 |
| 5770203 |
Modified cholera toxin based on mutagenized subunit A |
Jun. 23, 1998 |
| 5760184 |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
Jun. 2, 1998 |
| 5741680 |
Buffer composition base and method of formulation for oral vaccine delivery |
Apr. 21, 1998 |
|
|
|
